Refractory Plasma Cell Myeloma
Showing NaN - NaN of 7
Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,
Recruiting
- Advanced Malignant Solid Neoplasm
- +49 more
- Adavosertib
- +36 more
-
Birmingham, Alabama
- +1429 more
Aug 17, 2022
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Columbus (Bortezomib, Daratumumab and Hyaluronidase-fihj,
Recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Bortezomib
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Nov 30, 2021
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in United States (Carfilzomib, Dexamethasone, Laboratory
Completed
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Carfilzomib
- +2 more
-
Fairbanks, Alaska
- +484 more
Apr 3, 2020
Hematopoietic Cell Transplantation Recipient, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Columbus
Withdrawn
- Hematopoietic Cell Transplantation Recipient
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Feb 19, 2020
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Columbus (other, drug, biological)
Terminated
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Laboratory Biomarker Analysis
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
May 29, 2019
Light Chain Deposition Disease, Refractory Plasma Cell Myeloma Trial in Columbus (Diagnostic Laboratory Biomarker Analysis,
Completed
- Light Chain Deposition Disease
- Refractory Plasma Cell Myeloma
- Diagnostic Laboratory Biomarker Analysis
- Wild-type Reovirus
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Apr 14, 2015